Closing the Patient Care Gap in Autoimmunity

The Clinical Value of New Biomarkers

Tuesday, August 6, 7 – 8:30 a.m.
Hilton Anaheim, California B Room
Supported by Inova Diagnostics, Inc.


Clinicians, laboratorians, and patients have one goal in common—improving healthcare. Autoimmune diseases are challenging to diagnose due to the seronegative gap, often leading to delays in treatment for patients. With the development of new biomarkers and technologies, patients can receive a more accurate, earlier diagnosis including valuable information regarding risk stratification. We will discuss new biomarkers for autoimmune disease and present an advanced technology for multi-analyte testing.


Attendees will:

  • Understand the role of new biomarkers in closing the seronegative gap in autoimmunity.
  • Learn about an advanced technology for multi-analyte testing in autoimmunity.


Anna Eslami
Inova Diagnostics, Inc.
San Diego, CA


Xavier Bossuyt, MD, PhD
Katholeike Universiteit Leuven
Leuven, Belgium

Savino Sciascia, MD, PhD
University of Torino
Turin, Italy

Michael Mahler, PhD
Inova Diagnostics, Inc.
San Diego, CA